Mankind Pharma Ltd. Financials

NSE BSE

15:53 Sep 12

Mankind Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

2579.60

-19.40 (-0.75%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

2579.60

-19.40 (-0.75%)
15:53 Sep 12

Quality

45/100
Medium Financial Strength

Valuation

28/100
Expensive Valuation

Technical

64/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM 2025
Net Sales	7781.56	8749.43	10334.77	12207.44	12956.23
Operating Expenses +	5792.2	6848.79	7799.71	9189.51	9746.43
Raw Material	2871.31	2622.9	3263.37	3672.04	3765.7
Increase Decrease in Cost	-449.59	290.74	-53.67	-183	-26.62
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	1620.59	1918.47	2274.73	2692.37	2855.35
Miscellaneous Expenses	3377.39	3635.16	5134.98	6319.48	3152
Operating Profit	1989.36	1900.64	2535.06	3017.93	3209.8
Other Income	196.03	128.57	280.86	536.79	517.96
Depreciation	166.62	325.92	398.25	621.22	747.47
Interest	58.61	44.47	33.53	429.41	589.22
Profit before tax and exceptio..	1960.15	1658.81	2384.14	2504.09	2391.07
Exceptional Items	0	0	0	0	0
PBT	1960.15	1658.81	2384.14	2504.09	2391.07
Provision for Taxation	521.64	361.56	457.59	509.74	485.56
Net Profit	1438.51	1297.25	1926.56	1998.88	1901.17
NET Profit after MI	1433.48	1281.86	1912.9	1990.96	1892.79
EPS	35.78	32	47.68	49.2	46.58
Operating Profit Margin (%)	25.57	21.72	24.53	24.72	24.77
Net Profit Margin (%)	18.42	14.65	18.51	16.31	14.61

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	72.70	72.70	72.70	74.90	74.90
FII	13.10	12.90	13.30	12.40	11.60
MF	7.30	7.70	7.80	7.00	7.40
Others	4.10	3.80	3.30	2.80	2.50

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: